Cigna Q4 adjusted profit falls 8% on stop loss costs; 2025 outlook at least $29.50
The Cigna Group reported fourth quarter and full-year 2024 results on January 30, 2025. Full-year revenue rose 27% to $247.1 billion and adjusted income rose 4% to $7.7 billion, but fourth-quarter adjusted income fell 8% on higher stop loss medical costs at Cigna Healthcare, and GAAP net income fell to $3.4 billion from $5.2 billion after a $2.7 billion VillageMD impairment. The company projects 2025 adjusted income of at least $7.9 billion, or $29.50 per share, and raised its quarterly dividend 8% to $1.51 per share.
Key points
- Q4 2024 shareholders' net income was $1.4 billion ($5.13 per share), versus $1.0 billion ($3.49 per share) in Q4 2023; Q4 adjusted income was $1.8 billion ($6.64 per share), versus $2.0 billion ($6.79 per share).
- Full-year 2024 shareholders' net income of $3.4 billion ($12.12 per share) included a non-cash after-tax loss of $2.7 billion ($9.53 per share) tied to the VillageMD impairment.
- 2025 adjusted income from operations is projected at least $7.9 billion, or at least $29.50 per share.
- Quarterly dividend raised 8% to $1.51 per share, payable March 20, 2025; total share repurchase authorization is $10.3 billion after a $6.0 billion increase.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:21 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 30, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.